A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME)

Clinical trial NCT03499223 · COMPLETED

Trial details

NCT number: NCT03499223
Sponsor: Oxurion
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus Diabetic Retinopathy Macular Edema

Start date: 2018-04-20
Primary completion: 2019-07-18
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.